Mapping Of Services For Substance Use Disorders Report

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
B01AB05	ENOMEX	BioTech	Enoxaparin sodium - 2000U Anti-Xa/0.2ml	2000U Anti-Xa/0.2ml	Injectable solution	662,962 L.L
B01AB05	ENOXAMED	BioTech	Enoxaparin sodium - 10000IU Anti-XA/1ml	10000IU Anti-XA/1ml	Injectable solution	1,209,458 L.L
B01AB01	HEPARINE SODIQUE PANPHARMA	G	Heparin sodium - 25,000IU/5ml	25,000IU/5ml	Injectable solution	6,134,641 L.L
B01AB01	HEPARINE MEDIS	G	Heparin sodium - 25,000UI/5ml	25,000UI/5ml	Injectable solution	6,853,597 L.L
B01AA07	SINTROM	B	Acenocoumarol - 4mg	4mg	Tablet	490,183 L.L
A16AX	BICANORM	G	Sodium bicarbonate - 1000mg	1000mg	Tablet, gastroresistant	2,623,181 L.L
A16AB07	MYOZYME	BioTech	Alglucosidase alfa, recombinant human acid - 50mg	50mg	Injectable powder for concentrate for solution	L.L
A16AB07	MYOZYME	BioTech	Alglucosidase alfa, recombinant human acid - 50mg	50mg	Injectable powder for concentrate for solution	51,482,094 L.L
A16AB07	MYOZYME	BioTech	Alglucosidase alfa, recombinant human acid - 50mg	50mg	Injectable powder for concentrate for solution	L.L
A16AB05	ALDURAZYME	B	Laronidase - 100U/ml	100U/ml	Injectable concentrate for solution	57,138,680 L.L
A16AB04	FABRAZYME	BioTech	Agalsidase beta - 35mg	35mg	Injectable powder for concentrate for solution	L.L
A16AB04	FABRAZYME	BioTech	Agalsidase beta - 35mg	35mg	Injectable powder for concentrate for solution	295,038,213 L.L
A16AB04	FABRAZYME	BioTech	Agalsidase beta - 35mg	35mg	Injectable powder for concentrate for solution	L.L
A16AB02	CEREZYME	B	Imiglucerase - 400IU	400IU	Injectable lyophilised powder for solution	L.L
A16AB02	CEREZYME	B	Imiglucerase - 400IU	400IU	Injectable lyophilised powder for solution	128,412,818 L.L
A16AB02	CEREZYME	B	Imiglucerase - 400IU	400IU	Injectable lyophilised powder for solution	L.L
A15A	DYNAMOGEN	G	Arginine Aspartate - 1g/10ml, Glutodine (Cyproheptadine ?-ketoglutarate) - 3mg/10ml		Solution	1,019,976 L.L
A15	DESARROL	G	Cyproheptadine HCl - 0.2mg/ml, L-Arginine L-Aspartate - 25mg/ml, L-Carnitine - 50mg/ml		Solution	1,007,882 L.L
A13A	POTENCIATOR	G	Arginine Aspartate - 5g/10ml	5g	Solution	1,402,972 L.L
A12CX	PHOSPHATE DIPOTASSIQUE RENAUDIN	G	Phosphate dipotassique - 174.20mg/ml	174.20mg/ml	Injectable solution	1,189,301 L.L
A12CC	MAGNE B6	B	Pyridoxine HCl - 5mg, Magnesium lactate dihydrate - 470mg		Tablet, coated	365,525 L.L
A12CC	MAGNE B6	B	Pyridoxine HCl - 5mg, Magnesium lactate dihydrate - 470mg		Tablet, coated	365,525 L.L
A12CC	MAVIT	G	Magnesium - 100mg, Pyridoxine HCl - 10mg		Tablet	654,003 L.L
A12BA02	UROKIT	G	Potassium Citrate - 3g	3g	Powder for solution	1,628,737 L.L
A12BA01	EURO-K	G	Potassium chloride - 1.5g	1.5g	Tablet, sustained release	573,821 L.L
A12AX	DECALCIT	B	Vitamin D3 - 500IU, Calcium - 600mg		Tablet	912,469 L.L
A12AX	DECALCIT	B	Vitamin D3 - 500IU, Calcium - 600mg		Tablet	348,055 L.L
A12AX	OSTRONG	G	Vitamin D3 - 500IU, Calcium hydrogen phosphate - 600mg		Tablet	435,149 L.L
A12AX	DECALCIT	B	Vitamin D3 - 750IU, Calcium - 600mg		Powder	1,075,074 L.L
A12AX	CALPEROS D3 A SUCER	B	Vitamin D3 - 400IU, Calcium - 500mg		Tablet, chewable	667,890 L.L

تقرير مسح لخدمات الاستجابة لاستخدام المواد المسببة للإدمان - ٢٠١٧